Barthels M, Schramm W
Abteilung Hämatologie und Onkologie, Medizinische Hochschule Hannover, Germany.
Hamostaseologie. 2004 Nov;24(4):286-97. doi: 10.1267/hämo04040286.
Topics of this survey are the indications and use of plasma-derived and recombinant coagulation factor concentrates. These substitution therapies need to be handled carefully by weighing up their effectiveness against the long and short term side effects in the individual patient.
本次调查的主题是血浆源性和重组凝血因子浓缩物的适应症及使用。这些替代疗法需要谨慎处理,要权衡其对个体患者的有效性与长期和短期副作用。